Trial
NCT00740181
Decitabine, Cytarabine, GCSF for Refractory AML/MDS
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Brown University
Collaborators
Memorial Hospital of Rhode Island; Roger Williams Medical Center
Condition
Myelodysplasia
Intervention
chemotherapy
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-01-14